| Zachary Douglas Fisher, PA-C | |
|
257 S 625 E, Enterprise, UT 84725 | |
| (435) 669-6168 | |
| Not Available |
| Full Name | Zachary Douglas Fisher |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Location | 257 S 625 E, Enterprise, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851063176 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 12451849-1206 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Zachary Douglas Fisher, PA-C Po Box 1121, Enterprise, UT 84725-1121 Ph: (435) 669-6168 | Zachary Douglas Fisher, PA-C 257 S 625 E, Enterprise, UT 84725 Ph: (435) 669-6168 |
News Archive
Life Technologies Corporation, a provider of innovative life science solutions, today announced activities and product launches in concert with the International Society for Stem Cell Research (ISSCR) 8th Annual Meeting that highlight the company's offerings of complete end-to-end solutions for stem cell research. Stem cell research has been shown to be a critical component of regenerative medicine; a basis for identifying drug targets and drug screening; and an important step in the development of therapies to treat a variety of diseases.
Cells from individuals with Major Depressive Disorder (MDD) were found to have higher than expected rates of methylation at specific sites on their DNA, when compared to cells from healthy individuals without MDD, according to a study by a multidisciplinary team of UC San Francisco scientists, in collaboration with others.
An HIV prevention trial that pre-dates the shift to antiretroviral (ARV)-based approaches is nonetheless helping to answer some of the most relevant and topical questions the field is facing today.
Cancer cells do not grow equally well everywhere in the body. Often, they first create the conditions in which they can grow. Many years ago researchers discovered that solid tumors attract blood vessels to ensure their supply of nutrients by secreting specific factors.
Smoldering multiple myeloma patients with bone marrow plasma cell involvement should be treated immediately, say Italian researchers who found these patients are at greatest risk for symptomatic disease.
› Verified 6 days ago
Karl Torgerson, P.A. Physician Assistant Medicare: Medicare Enrolled Practice Location: 223 S 200 E, Enterprise, UT 84725 Phone: 435-878-2281 |